King, Laura Andrejko, Kristin Kabbani, Sarah Tartof, Sara Hicks, Lauri Cohen, Adam Kobayashi, Miwako Lewnard, Joseph
BACKGROUND: In 2022-2023, 15- and 20-valent pneumococcal conjugate vaccines (PCV15/PCV20) were recommended for infants. We aimed to estimate the incidence of outpatient visits and antibiotic prescriptions in US children (≤17 years) from 2016-2019 for acute otitis media, pneumonia, and sinusitis associated with PCV15- and PCV20-additional (non-PCV13...
Hirose, Yujiro Zielinski, Daniel Poudel, Saugat Rychel, Kevin Baker, Jonathon Toya, Yoshihiro Yamaguchi, Masaya Heinken, Almut Thiele, Ines Kawabata, Shigetada
...
Streptococcus pyogenes is responsible for a range of diseases in humans contributing significantly to morbidity and mortality. Among more than 200 serotypes of S. pyogenes, serotype M1 strains hold the greatest clinical relevance due to their high prevalence in severe human infections. To enhance our understanding of pathogenesis and discovery of p...
Kiemel, Dominik; Kroell, Ann-Sophie Helene; Denolly, Solene; Haselmann, Uta; Bonfanti, Jean-Francois; Andres, Jose Ignacio; Ghosh, Brahma; Geluykens, Peggy; Kaptein, Suzanne J.F.; 51996; Wilken, Lucas;
...
Dengue fever represents a significant medical and socio-economic burden in (sub)tropical regions, yet antivirals for treatment or prophylaxis are lacking. JNJ-A07 was described as highly active against the different genotypes within each serotype of the disease-causing dengue virus (DENV). Based on clustering of resistance mutations it has been ass...
Cerpas, Cristhiam Vásquez, Gerald Moreira, Hanny Juarez, Jose Coloma, Josefina Harris, Eva Bennett, Shannon Balmaseda, Ángel
Major dengue epidemics throughout Nicaraguas history have been dominated by 1 of 4 dengue virus serotypes (DENV-1-4). To examine serotypes during the dengue epidemic in Nicaragua in 2022, we performed real-time genomic surveillance in-country and documented cocirculation of all 4 serotypes. We observed a shift toward co-dominance of DENV-1 and DENV...
Kesteleyn, Bart; Bonfanti, Jean-Francois; Bardiot, Dorothee; De Boeck, Benoit; Goethals, Olivia; Kaptein, Suzanne J.F.; 51996; Stoops, Bart; Coesemans, Erwin; Fortin, Jerome; Muller, Philippe;
...
Dengue is a global public health threat, with about half of the world's population at risk of contracting this mosquito-borne viral disease. Climate change, urbanization, and global travel accelerate the spread of dengue virus (DENV) to new areas, including southern parts of Europe and the US. Currently, no dengue-specific small-molecule antiviral ...
Abuhasan, Musallam Yunus Albayat, Soha Shawqi A. Bai, Xilian Bastaki, Hamad Borrow, Ray Dbaibo, Ghassan Deghmane, Ala-Eddine Dinleyici, Ener Cagri Ghuneim, Nedal Sheek-Hussein, Mohamud
...
This review details recent findings from the Global Meningococcal Initiative’s (GMI) recent meeting on the surveillance and control strategies for invasive meningococcal disease in the Middle East. The nature of case reporting and notification varies across the region, with many countries using bacterial meningitis as an IMD case definition in lieu...
Graber, Aaron Cardona-Ospina, Jaime Duarte, Elias Zambrana, Jose Ruíz Salinas, Jorge Mercado-Hernandez, Reinaldo Singh, Tulika Katzelnick, Leah de Silva, Aravinda Kuan, Guillermina
...
Dengue viruses (DENV1-4) are the most prevalent arboviruses in humans and a major public health concern. Understanding immune mechanisms that modulate DENV infection outcome is critical for vaccine development. Neutralizing antibodies (nAbs) are an essential component of the protective immune response, yet their measurement often relies on a single...
Porwollik, Steffen Chu, Weiping Desai, Prerak T McClelland, Michael
Genetic screening of pools of mutants can reveal genetic determinants involved in complex biological interactions, processes, and systems. We previously constructed two single-gene deletion resources for Salmonella enterica serovar Typhimurium 14028s in which kanamycin (KanR) and chloramphenicol (CamR) cassettes were used to replace non-essential g...
Hurst, Jillian Shaik-Dasthagirisaheb, Yazdani Truong, Loc Boiditswe, Sefelani Patel, Sweta Gilchrist, Jodi Maciejewski, Julia Luinstra, Kathy Smieja, Marek Steenhoff, Andrew
...
BACKGROUND: In 2012, Botswana introduced 13-valent pneumococcal conjugate vaccine (PCV-13) to its childhood immunization program in a 3+0 schedule, achieving coverage rates of above 90% by 2014. In other settings, PCV introduction has been followed by an increase in carriage or disease caused by non-vaccine serotypes, including some serotypes with ...
Gamsjäger, Lisa Chigerwe, Munashe
BACKGROUND: There is only limited information on the clinical presentation, medical management, and outcomes of hospitalized sheep diagnosed with bluetongue virus (BTV) disease. OBJECTIVES: To describe the signalment, history, clinical signs, clinicopathological findings, medical management, and clinical outcomes of sheep diagnosed with BTV disease...